NCT05559008 2022-11-09
A Umbrella Study in R/R PTCL Guided by Molecular Subtypes
Ruijin Hospital
Phase 1/2 Unknown
Clinical Trials
5 trialsNCT04476459 2021-03-15
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
Sun Yat-sen University
Phase 1/2 Unknown
NCT03376958 2019-07-25
Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Zhengzhou University
Phase 4 Completed
NCT03701022 2018-10-09
PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma
Peking University
Phase 2 Unknown
NCT03631862 2018-08-15
Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
Zhengzhou University
Phase 4 Unknown